Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-05-01-2016
Volume36
Issue 5

Pharmaceutical Executive, May 2016 Issue (PDF)

Click the title above to open the Pharmaceutical Executive May 2016 issue in an interactive PDF format.

External Link - PharmExec_ Regular Issue _May2016.pdf

Download Issue PDF
Articles in this issue
Steering the Change: GSK's Jack Bailey
Steering the Change: GSK's Jack Bailey
Pharma’s Big Push for Value
Pharma’s Big Push for Value
Pharm Exec at the Vantage Point
Pharm Exec at the Vantage Point
Jill thumbnail.jpg
Pharma Under Pressure to Curb Opioid Abuse
i1.jpg
Country Report: France
Pharmaceutical Executive, May 2016 Issue (PDF)

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
Gilead Subsidiary Kite to Acquire Interius BioTherapeutics for $350 Million
August 23rd 2025

Gilead Subsidiary Kite to Acquire Interius BioTherapeutics for $350 Million

Don Tracy, Associate Editor
The Rx for High-Performance Leadership: Cutting Through the Chaos
August 23rd 2025

The Rx for High-Performance Leadership: Cutting Through the Chaos

Michael Christel
Stock.adobe.com
August 23rd 2025

Lighthouse Pharmaceuticals Awarded $49.2 Million Grant from NIA to Advance Phase 2 study of LHP588

Nicholas Jacobus
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
August 23rd 2025

Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

Miranda Schmalfuhs
© WESTOCK - © WESTOCK - stock.adobe.com
August 23rd 2025

Supreme Court Upholds NIH Funding Cuts Affecting DEI in Clinical Research

Andy Studna
XOMA Royalty Subsidiary to Acquire Mural Oncology in Premium Cash Transaction
August 23rd 2025

XOMA Royalty Subsidiary to Acquire Mural Oncology in Premium Cash Transaction

Don Tracy, Associate Editor